Trial
NCT00359151
Celebrex Total Knee Arthroplasty Study
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Osteoarthritis
Intervention
Celecoxib
Why stopped
This study was terminated early due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-03